Abstract Outcomes of Ketamine IV Treatments for TMS Therapy Poor Responders
Main Author: | Erin Amato |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Brain Stimulation |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X20301509 |
Similar Items
-
Brainsway™ dTMS (TMS) and Brainsway™ dTMS with Ketamine Infusions (TMSK) in Treatment-Resistant Depression (TRD); Real life results
by: Diana Ghelber, et al.
Published: (2018-11-01) -
Assessment of the separation of responders and non-responders to rTMS for treatment refractory MDD
by: Jesse Bastiaens, et al.
Published: (2018-11-01) -
Differentiating Responders and Non-responders to rTMS Treatment for Disorder of Consciousness Using EEG After-Effects
by: Renhong He, et al.
Published: (2020-11-01) -
Clinical Outcomes of TMS treatment
by: Yu Kawaguchi, MD
Published: (2015-09-01) -
61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial
by: Agustin G. Yip, et al.
Published: (2017-07-01)